EDSA · Edesa Biotech, Inc.
AI read · Good for EDSA
The AI's read
This gives Edesa a way to recruit patients in the United States and broaden its EB06 study. Clearance does not show that the drug works. Safety and benefit still need testing, and results are not expected until Q4 2027. The added U.S. reach is a concrete step, so the news reads positively despite the wait and unanswered trial questions.